Is the NOD mouse a good model for type 1 diabetes?
Open Access
- 8 November 2025
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 69 (1) , 3-19
Abstract
The NOD mouse is the best-known, although by no means the only, murine model of type 1 diabetes. In this review, we provide a historical perspective, particularly highlighting areas of progress in understanding aspects of aetiology and immune pathogenesis, and utility in helping to shape the immunotherapeutic landscape. We introduce points of interest where the NOD mouse, a much-studied model, has signposted discovery and knowledge. We discuss genetics, pancreatic islet beta cell stress, innate and adaptive immunity and autoantigens, and also focus on immunotherapeutic agents that have been tested in NOD mice and in humans. Some therapies, particularly those that are non-antigen-specific, have been more effectively signposted, while others, which include antigen-specific therapies, have not. There is an inevitable divergence between mice and humans that illustrates the need to use models appropriately. We suggest how to make use of this and other models effectively in order to maximise information and knowledge, and suggest not dismissing this important resource because of inappropriate comparisons or unrealistic expectations. Graphical AbstractKeywords
This publication has 156 references indexed in Scilit:
- Rat Models of Human Type 1 Diabetes2020
- Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 DiabetesJAMA, 2015
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in ChildrenJAMA, 2013
- A missing link in the hygiene hypothesis?Diabetologia, 2002
- Oral Administration of Insulin to Neonates Suppresses Spontaneous and Cyclophosphamide Induced Diabetes in the NOD MouseJournal of Autoimmunity, 2001
- A Major Gene Affecting Age-Related Hearing Loss Is Common to at Least Ten Inbred Strains of MiceGenomics, 2000
- Administering Glutamic Acid Decarboxylase to NOD Mice Prevents DiabetesJournal of Autoimmunity, 1994
- Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-? antibodyDiabetologia, 1991
- Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1987
- The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United KingdomDiabetologia, 1986